X. Dhalluin

543 total citations
24 papers, 278 citations indexed

About

X. Dhalluin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, X. Dhalluin has authored 24 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Surgery. Recurrent topics in X. Dhalluin's work include Pleural and Pulmonary Diseases (7 papers), Occupational and environmental lung diseases (7 papers) and Lung Cancer Treatments and Mutations (6 papers). X. Dhalluin is often cited by papers focused on Pleural and Pulmonary Diseases (7 papers), Occupational and environmental lung diseases (7 papers) and Lung Cancer Treatments and Mutations (6 papers). X. Dhalluin collaborates with scholars based in France, Cambodia and Belgium. X. Dhalluin's co-authors include Arnaud Scherpereel, Benoît Colinet, J.J. Lafitte, Nathalie Leclercq, Jean‐Paul Sculier, Anne‐Pascale Meert, Thierry Berghmans, Luc Willems, Michel Richez and Alexis B. Cortot and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and Annals of Oncology.

In The Last Decade

X. Dhalluin

21 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
X. Dhalluin France 8 167 56 54 50 40 24 278
Satish Shah United States 7 66 0.4× 25 0.4× 31 0.6× 25 0.5× 17 0.4× 19 172
Shaun Bender United States 13 276 1.7× 35 0.6× 26 0.5× 44 0.9× 39 1.0× 38 396
Xiaowen Wang China 9 234 1.4× 65 1.2× 66 1.2× 124 2.5× 11 0.3× 15 331
Dimitrios Giannakidis Greece 11 79 0.5× 29 0.5× 51 0.9× 44 0.9× 11 0.3× 38 264
Yoshitaro Yoshida Japan 6 30 0.2× 66 1.2× 68 1.3× 78 1.6× 10 0.3× 12 270
Charilaos Koulouris Greece 11 75 0.4× 22 0.4× 42 0.8× 93 1.9× 18 0.5× 40 259
Zhanjun Qiu China 10 47 0.3× 86 1.5× 32 0.6× 33 0.7× 10 0.3× 24 270
Mitsunori Hino Japan 11 206 1.2× 95 1.7× 109 2.0× 28 0.6× 13 0.3× 35 338
Adrian Tulin Romania 7 47 0.3× 55 1.0× 23 0.4× 53 1.1× 14 0.3× 37 202
Rachel A. Ness United States 4 43 0.3× 31 0.6× 48 0.9× 11 0.2× 37 0.9× 6 176

Countries citing papers authored by X. Dhalluin

Since Specialization
Citations

This map shows the geographic impact of X. Dhalluin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Dhalluin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Dhalluin more than expected).

Fields of papers citing papers by X. Dhalluin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X. Dhalluin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Dhalluin. The network helps show where X. Dhalluin may publish in the future.

Co-authorship network of co-authors of X. Dhalluin

This figure shows the co-authorship network connecting the top 25 collaborators of X. Dhalluin. A scholar is included among the top collaborators of X. Dhalluin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with X. Dhalluin. X. Dhalluin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gounant, V., M. Duruisseaux, Olivier Bylicki, et al.. (2021). Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients. Cancers. 13(5). 1040–1040. 9 indexed citations
3.
Chouaïd, C., et al.. (2021). Salvage Immunotherapy With Pembrolizumab in Patients Hospitalized for Life-Threatening Complications of NSCLC. JTO Clinical and Research Reports. 2(5). 100147–100147. 5 indexed citations
4.
Dangers, Laurence, Jonathan Giovannelli, G. Mangiapan, et al.. (2020). Antiplatelet Drugs and Risk of Bleeding After Bedside Pleural Procedures. CHEST Journal. 159(4). 1621–1629. 9 indexed citations
5.
Hamroun, Aghilès, Jean Joël Bigna, Élodie Speyer, et al.. (2019). Prevention of Cisplatin-Induced Acute Kidney Injury: A Systematic Review and Meta-Analysis. Drugs. 79(14). 1567–1582. 62 indexed citations
6.
Dhalluin, X., et al.. (2019). Can Studies on Early Palliative Care Be Harmful to Patient Well Being?. Journal of Palliative Medicine. 22(12). 1488–1488. 2 indexed citations
7.
Camuset, Juliette, Jean‐Marc Naccache, X. Dhalluin, et al.. (2019). Cryobiopsies trans-bronchiques au cours des pneumopathies interstielles diffuses – expériences préliminaires. Revue des Maladies Respiratoires. 36(4). 455–460. 3 indexed citations
8.
Fournier, C., Lidwine Wémeau-Stervinou, M.C. Copin, et al.. (2017). Cryobiopsies transbronchiques dans le diagnostic des pneumopathies interstitielles diffuses : résultats préliminaires. Revue des Maladies Respiratoires. 34. A124–A125. 2 indexed citations
9.
Brosseau, Solenn, X. Dhalluin, Gérard Zalcman, & Arnaud Scherpereel. (2017). Immunotherapy in Relapsed Mesothelioma. Immunotherapy. 10(2). 77–80. 3 indexed citations
10.
Dhalluin, X. & Arnaud Scherpereel. (2016). Treatment of malignant pleural mesothelioma: current status and future directions. Monaldi Archives for Chest Disease. 73(2). 79–85.
11.
Dangers, Laurence, G. Mangiapan, Mikaël Alves, et al.. (2015). Bleeding risk of pleural procedures in patients taking antiplatelet therapy: A multicentric prospective study. PA2487–PA2487. 2 indexed citations
12.
Bouchindhomme, B., Nunzia Tacelli, X. Dhalluin, et al.. (2013). La maladie de Castleman : observations inhabituelles et revue de la littérature. Revue de Pneumologie Clinique. 69(1). 55–59. 1 indexed citations
13.
Escande, Fabienne, B. Bouchindhomme, M.C. Copin, et al.. (2013). Faisabilité de la recherche de mutations EGFR et KRAS sur des prélèvements obtenus par EBUS-PTBA. Revue des Maladies Respiratoires. 30(5). 351–356. 7 indexed citations
14.
Huret, Bruno, et al.. (2013). Traitement par bronchoscopie rigide de l’obstruction maligne des voies aériennes centrales. Revue des Maladies Respiratoires. 32(5). 477–484. 7 indexed citations
15.
Dhalluin, X., et al.. (2013). Prise en charge diagnostique et thérapeutique du mésothéliome pleural malin. Revue de Pneumologie Clinique. 69(1). 26–35. 5 indexed citations
16.
Dhalluin, X., G. Petyt, Nunzia Tacelli, et al.. (2013). Bevacizumab and weekly paclitaxel for non-squamous non small cell lung cancer patients: A retrospective study. Lung Cancer. 80(2). 197–202. 19 indexed citations
17.
18.
Leroy, Sylvie, Arnaud Scherpereel, X. Dhalluin, et al.. (2013). Outpatient management of primary spontaneous pneumothorax: a prospective study. European Respiratory Journal. 43(2). 582–590. 41 indexed citations
19.
Dhalluin, X. & Arnaud Scherpereel. (2011). Chemotherapy and Radiotherapy for Mesothelioma. Recent results in cancer research. 189. 127–147. 9 indexed citations
20.
Scherpereel, Arnaud, Thierry Berghmans, J.J. Lafitte, et al.. (2010). Valproate–doxorubicin: promising therapy for progressing mesothelioma. A phase II study. European Respiratory Journal. 37(1). 129–135. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satish Shah Breakdown of academic impact, for papers by Shaun Bender Breakdown of academic impact, for papers by Xiaowen Wang Breakdown of academic impact, for papers by Dimitrios Giannakidis Breakdown of academic impact, for papers by Yoshitaro Yoshida Breakdown of academic impact, for papers by Charilaos Koulouris Breakdown of academic impact, for papers by Zhanjun Qiu Breakdown of academic impact, for papers by Mitsunori Hino Breakdown of academic impact, for papers by Adrian Tulin Breakdown of academic impact, for papers by Rachel A. Ness
Rankless by CCL
2026